Zusammenfassung
Es ist anzunehmen, daß das humane Parvovirus-B19 (PV-B19) aufgrund seiner hohen Resistenz gegenüber Umwelteinflüssen sowie seiner hochgradigen Virämie bei Infizierten (1011-1014 Genomkopien/ml Serum) zu den Viren gezählt werden muß, die mit Gerinnungsfaktorpräparaten übertragen werden können [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Frickhofen N, Young NS (1991) A rapid method of sample preparation for detection of DNA viruses in human serum by polymerase chain reaction. I Virol Methods 35:65–72
Schwarz TF, Jäger G, Holzgreve W, Roggendorf M (1992) Diagnosis of human parvovirus B 19 infection by polymerase chain reaction. Scand J Infect Dis 24:691–696
Kwok S, Higuchi R (1989) Avoiding false positives with PCR. Nature 339:237–238
Bowman CA, Cohen BJ, Norfolk DR, Lacey CJN (1990) Red cell aplasia associated with human parvovirus B 19 and HIV infection: failure to respond clinically to intravenous immunoglobulin. AIDS 4:1038–1039
Nigro G, Luzi G, Fridell E, Ferrara M, Pisano P, Gattinara GC, Mezzaroma I, Söderlund M, Rasnoveanu D, Aiuti F (1992) Parvovirus infection in children with AIDS: high prevalence of B 19-specific immunoglobulin M and G antibodies. AIDS 6:679–684
Cohen BJ, Field AM, Gudnadottir S, Beard S, Barbara JAJ (1990) Blood donor screening for parvovirus B 19. J Virol Methods 30:233–238
McOmish F, Yap PL, Jordan A, Hart H, Cohen BJ, Simmonds P (1993) Detection of parvovirus B 19 in donated blood: a model system for screening by polymerase chain reaction. J Med Virol J Clin Microbiol 31:323–328
Lyon DJ, Chapman CS, Martin C, Brown KE, Clewley JP, Flower AJE, Mitchell VE (1989) Symptomatic parvovirus B 19 infection and heat-treated factor IX concentrate. Lancet i: 1085
Morfini M, Longo G, Rossi Ferrini P, Azzi A, Zakrewska C, Ciappi S, Kolumban P (1992) Hypoplastic anaemia in a hemophiliac first infused with a solvent/detergent treated factor VIII concentrate: the role of human B 19 parvovirus. Am J Hematol 39:149–150
Rollag H, Patou G, Pattison JR, Degré M, Evensen SA, Fröland SS, Glomstein A (1991) Prevalence of antibodies against parvovirus B 19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools. Scand J Infect Dis 23:675–679
Williams MD, Cohen BJ, Beddall AC, Pasi KJ, Mortimer PP, Hill FGH (1990) Transmission of human parvovirus B 19 by coagulation factor concentrates. Vox Sang 58:177–181
Schwarz TF, Roggendorf M, Hottenträger B, Stolz W, Schwinn H (1991) Removal of parvovirus B 19 from contaminated factor VIII during fractionation. J Med Virol 35:28–31
Zakrzewska K, Azzi A, Patou G, Morfini M, Rafanelli D, Pattison JR (1992) Human parvovirus B 19 in clotting factor concentrates: B 19 DNA detection by the nested polymerase chain reaction. Br J Haematol 81:407–412
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Grosse-Bley, A. et al. (1993). Parvovirus-B19-Infektionen bei Hämophilen. In: Scharrer, I., Schramm, W. (eds) 23. Hämophilie-Symposion. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78359-3_33
Download citation
DOI: https://doi.org/10.1007/978-3-642-78359-3_33
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56955-8
Online ISBN: 978-3-642-78359-3
eBook Packages: Springer Book Archive